2022-03-24 6:0:00.0 Investing in TB prevention strategies with Long-Acting injectables

2022-03-24 6:0:00.0 Reducing the burden of TB in the world’s most in need communities with long-acting injectables

2022-03-24 6:0:00.0 Living with TB - my experience

2022-04-25 6:0:00.0 Delivering innovations to low- and middle-income countries

2022-04-24 6:0:00.0 Saving lives through long-acting injectable innovation

2022-07-28 24:0:00.0 Developing a single-injection cure for hepatitis C virus for low- and middle-income countries

2022-07-28 24:0:00.0 Community engagement – shaping the long-acting technologies pipeline

2022-12-01 24:0:00.0 Researchers from the Centre of Excellence for Long-acting Therapeutics featured prominently in leading scientific journal for clinical infectious diseases

2023-08-07 7:47:37.0 Liverpool host LONGEVITY consortium

2024-04-17 7:47:00.0 Doctors in low- and middle-income countries say ‘yes’ to long-acting treatments for Hepatitis C

2024-12-05 7:47:00.0 Patients in low- and middle- income countries are enthusiastic about long-acting injections to treat hepatitis C virus.